With 37 Novel Approvals in 2022, US FDA CDER’s Five-Year Hot Streak Comes To An End; Gene Therapies Carry CBER To 8 Novel Approvals

 
• By Bridget Silverman
NME plunge perspectives
FDA novel Rx approvals plunged 25% in 2022. • Source: Shutterstock

More from Approvals

More from Product Reviews